Difficulty distribution
How the classified questions are distributed by difficulty.
Your cart is empty.
Practice Recombinant DNA technology and Other Tools in Biotechnology - Biotechnology previous year questions organised from real papers, with year-wise coverage and clear topic navigation.
Every graph below is calculated only from this selection.
Compare question counts across years.
How the classified questions are distributed by difficulty.
MCQ, numerical, multiple-select and other formats found in these papers.
Top subjects by unique question coverage.
Top topics across the included previous year papers.
Top subtopics inside this exact selection.
Question coverage for the most populated papers. Every active PYP paper remains listed below.
Open a focused page built from the same verified paper data.
Explore previous-paper coverage, trends and focused practice for Molecular tools.
Explore previous-paper coverage, trends and focused practice for Computational tools.
Explore previous-paper coverage, trends and focused practice for Analytical tools.
Explore previous-paper coverage, trends and focused practice for Recombinant DNA technology.
Newest papers appear first. Search these papers or sort by year and name.
| Paper name | Year | Attempt | |
|---|---|---|---|
Biotechnology (BT) 20262026 | 2026 |
|
|
Biotechnology (BT) 20252025 | 2025 | |
|
Biotechnology (BT) 20242024 | 2024 | |
|
Biotechnology (BT) 20232023 | 2023 | |
|
Biotechnology (BT) 20222022 | 2022 | |
|
Biotechnology (BT) 20212021 | 2021 | |
|
Biotechnology (BT) 20202020 | 2020 | |
|
Biotechnology (BT) 20192019 | 2019 | |
|
Biotechnology (BT) 20182018 | 2018 | |
|
Biotechnology (BT) 20172017 | 2017 | |
|
Biotechnology (BT) 20162016 | 2016 | |
|
Biotechnology (BT) 20142014 | 2014 | |
|
Biotechnology (BT) 20132013 | 2013 | |
|
Biotechnology (BT) 20122012 | 2012 | |
|
Biotechnology (BT) 20112011 | 2011 | |
|
Biotechnology (BT) 20102010 | 2010 | |
|
A varied preview from the papers represented in this selection, with every available option.
The first humanized monoclonal antibody approved for the treatment of breast cancers
Which one of the following is NOT a therapeutic agent based on nucleic acid for the treatment of genetic disorders?